Huaige Capital
VC Fund
Shanghai, China
Huaige Capital is a venture capital focusing on healthcare sector.
- Total investments:
- 23
- Last investment:
- Lead investor:
- 30%
Last updated:
For AI agents: llms.txt
Industries Huaige Capital invests in
Stages Huaige Capital invests in
Countries Huaige Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Angel
- $425k–$14M
- Series A
- $2.8M–$36M
Investment Focus
Industry
- Medical 9 (39%)
- Health Care 9 (39%)
- Biotechnology 9 (39%)
- Pharmaceutical 6 (26%)
- Biopharma 5 (22%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Kai Wang
Founder
|
Founder | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Xianyan Biopharma
|
Xianyan Biopharma is a company that focuses on core technology innovation and new medication development for oligonucleotides, and it has a top-tier R&D staff. | $21.8M / Series A / Mar 20, 2026 | |
|
Heerkang
|
Heerkang is a medical technology company that provides medical device research and sales, and health consultation services. | Series A / Nov 04, 2025 | |
Yili Pharmaceutical
|
Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development. | $14M / Angel / Sep 25, 2025 | |
|
Venus Medical
|
Venus Medical develops medical aesthetic products using silk fibroin gene editing and ECM-like matrix technology, offering three filler injections and two dressings. | Seed / Sep 10, 2025 | |
|
Xianyan Biopharma
|
Xianyan Biopharma is a company that focuses on core technology innovation and new medication development for oligonucleotides, and it has a top-tier R&D staff. | $14.1M / Venture - Series Unknown / Aug 29, 2024 | |
Xinhengrui Medical
|
Xinhengrui Medical provides heart-assisted medical devices and offers complete, safe, and effective intelligent mechanical-assisted therapy solutions for heart failure patients. | $13.9M / Series A / Jul 17, 2023 | |
Affinity
|
Affinity Biomedical Technology is a clinical biopharmaceutical company focusing on the development of global innovative anticancer drugs. | Series B / Jul 06, 2023 | |
Yineng Pharma
|
Eneng Medicine is a national high-tech enterprise focusing on the development of new Chinese medicines and natural medicines. | $14.6M / Series A / Mar 30, 2023 | |
Enochic
|
Enochic is a synthetic biology platform provider. | $7.1M / Angel / Jan 05, 2023 | |
Enokiko
|
Enokiko is a provider of synthetic biology platforms oriented to the study, creation, and manufacturing of environmentally friendly biological products. | $7.3M / Angel / Jan 05, 2023 | |
| See all 23 investments → | |||
Co-Investors
ALAN AMC
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Huaige Capital invest in?
Huaige Capital invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A and Angel stage. Most of the 23 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Huaige Capital's check size?
Huaige Capital typically joins rounds of $425k–$14M at Angel and $2.8M–$36M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Huaige Capital participates in.
How do I contact Huaige Capital?
Public channels for Huaige Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Huaige Capital?
The team at Huaige Capital includes Kai Wang (Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
